6 terminated. 6 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 3 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Suicidal Ideation: new trials by email Literature Review of Suicidal Ideation trials Research Report on Suicidal Ideation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SAINT for MDD in an Inpatient Setting Follow-on Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode | Phase 2 / Phase 3 | Terminated | Magnus Medical | 2 | 2024-06-30 | 2025-03-24 |
| The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition Active SAINT Stimulation, Sham SAINT Stimulation - Major Depressive Disorder, Major Depressive Episode | Phase 2 / Phase 3 | Terminated | Magnus Medical | 2 | 2024-06-30 | 2025-03-24 |
| Ketamine for OUD and Suicidal Ideation in the ED Ketamine, Saline Solution - Opioid Use Disorder, Suicidal Ideation | Phase 2 | Terminated | Brigham and Women's Hospital | 4 | 2024-06-14 | 2025-04-08 |
| Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics Ketamine Injectable Solution, Midazolam Injectable Solution, Normal Saline 0.9% Injectable Solution - Suicidal Ideation | Phase 1 / Phase 2 | Terminated | University of British Columbia | 15 | 2022-06-01 | 2024-12-18 |
| A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic OTX-202, OTX-000, Treatment as Usual - Suicide, Attempted, Suicidal Ideation | Phase 2 / Phase 3 | Terminated | Oui Therapeutics, Inc. | 356 | 2022-04-07 | 2025-06-12 |
| Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent MIJ821 Intravenous Injection, Placebo Intravenous Injection - Major Depressive Disorder With Suicidal Ideation With Intent | Phase 2 | Terminated | Novartis Pharmaceuticals | 199 | 2021-07-20 | 2026-05-18 |
Depression (3) · Depressive Disorder, Major (3) · Mental Disorders (1) · Mood Disorders (1) · Opioid-Related Disorders (1) · Self-Injurious Behavior (1) · Suicide (1) · Suicide, Attempted (1)
Behavior (6) · Behavioral Symptoms (6) · Self-Injurious Behavior (5) · Suicide (5) · Depressive Disorder (3) · Mental Disorders (3) · Mood Disorders (2) · Chemically-Induced Disorders (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
Saline Solution (2) · Ketamine (1) · Therapeutics (1)
Magnus Medical (2) · Brigham and Women's Hospital (1) · Novartis Pharmaceuticals (1) · Oui Therapeutics, Inc. (1) · University of British Columbia (1)
United States (5) · Canada (2) · Argentina (1) · Brazil (1) · Germany (1) · Japan (1) · Malaysia (1) · Mexico (1) · Netherlands (1) · Poland (1) · Russia (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1)
Brandon Bentzley, MD (2) · Quynh Doan, PhD MHSc MD (1)
R01MH125160 (1), R42MH123357 (1)